Santen Pharmaceutical
4536.T
#3008
Rank
$4.29 B
Marketcap
$12.26
Share price
-1.56%
Change (1 day)
41.11%
Change (1 year)

Earnings for Santen Pharmaceutical (4536.T)

Earnings in 2024 (TTM): $0.22 Billion USD

According to Santen Pharmaceutical 's latest financial reports the company's current earnings are $2.06 Billion USD. In 2023 the company made an earning of $0.28 Billion USD, an increase over its 2022 earnings that were of $26.44 Million USD. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Santen Pharmaceutical from 2009 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) $0.22 B-21.61%
2023 $0.28 B996.55%
2022 $26.44 M-75.14%
2021 $0.10 B-65.28%
2020 $0.30 B-18.35%
2019 $0.37 B-4.37%
2018 $0.39 B22.65%
2017 $0.31 B0.6%
2016 $0.31 B-55.76%
2015 $0.71 B164.91%
2014 $0.27 B-3.69%
2013 $0.28 B-11.62%
2012 $0.31 B-19.83%
2011 $0.39 B29.29%
2010 $0.30 B1.35%
2009 $0.30 B